Efficacy of underwater endoscopic mucosal resection for sessile serrated lesions.
Not Applicable
Recruiting
- Conditions
- sessile serrated lesion
- Registration Number
- JPRN-UMIN000041171
- Lead Sponsor
- Okayama University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 102
Inclusion Criteria
Not provided
Exclusion Criteria
Suspicious of cancer or adenoma Familial adenomatous polyposis Inflammatory bowel disease Infectious disease with systemic therapy indicated Pregnant or nursing Impossible to perform UEMR due to antithrombotic drugs Short prognosis (within one year) Other inappropriate cases
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method complete resection rate
- Secondary Outcome Measures
Name Time Method R0 resection rate En bloc resection rate Recurrence rate Procedure time difficult-to-resect factors of UEMR Adverse events Histology
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of underwater endoscopic mucosal resection in sessile serrated lesions?
How does underwater endoscopic mucosal resection compare to standard endoscopic techniques for sessile serrated lesion removal?
Are there specific biomarkers that predict optimal outcomes with underwater endoscopic mucosal resection in colorectal serrated lesions?
What are the long-term adverse event profiles associated with underwater endoscopic mucosal resection for sessile serrated lesions?
What combination therapies or alternative approaches are being explored alongside underwater endoscopic mucosal resection for serrated colorectal neoplasia?